As a biologist who specializes in molecular and cellular biology, I apply my expertise and knowledge to ensure timely and accurate high-throughput detection of genetic aberrations in cancer tissue.
My translational research in cancer genomics involves the creation and development of necessary clinical assays derived from molecular biology innovations. These clinical assessments are able to identify the nucleic acid alterations within human cancers that are used by pathologists and oncologists to genetically diagnose cancers (molecular diagnostics), to assist in patient-personalized treatment decisions (therapeutic guidance), and to establish a prognosis (prognostic stratification).
My primary goal is to make a difference in the care and treatment of our cancer patients.
- Clinical Expertise: Molecular Diagnostics
- Languages Spoken: English; French
- Education: PhD, University of Nice Sophia Anitpolis (France)
- Fellowships: Memorial Sloan Kettering Cancer Center
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more